New combo treatment tested to shrink lung tumors before surgery
NCT ID NCT03237377
Summary
This small, early-stage study tested a new approach for patients with stage III non-small cell lung cancer that could be removed with surgery. The goal was to see if giving two immunotherapy drugs along with radiation before the operation was safe and practical. Researchers wanted to learn if this 'immunoradiation' could shrink tumors and improve outcomes without causing too many side effects or delaying surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.